Congenital semilunar valvulogenesis defect in mice deficient in phospholipase Cε
Congenital semilunar valvulogenesis defect in mice deficient in phospholipase Cε
复制标题
DOI:
10.1128/mcb.25.6.2191-2199.2005
复制
发表时间:
2005-03-01
影响因子:
5.3
通讯作者:
Kataoka, T
中科院分区:
文献类型:
--
作者:
Tadano, M;Edamatsu, H;Kataoka, T
Phospholipase Cepsilon is a novel class of phosphoinositide-specific phosphollipase C, identified as a downstream effector of Ras and Rap small GTPases. We report here the first genetic analysis of its physiological function with mice whose phospholipase Cepsilon is catalytically inactivated by gene targeting. The hearts of mice homozygous for the targeted allele develop congenital malformations of both the aortic and pulmonary valves, which cause a moderate to severe degree of regurgitation with mild stenosis and result in ventricular dilation. The malformation involves marked thickening of the valve leaflets, which seems to be caused by a defect in valve remodeling at the late stages of semilunar valvulogenesis. This phenotype has a remarkable resemblance to that of mice carrying an attenuated epidermal growth factor receptor or deficient in heparin-binding epidermal growth factor-like growth factor. Smad1/5/8, which is implicated in proliferation of the valve cells downstream of bone morphogenetic protein, shows aberrant activation at the margin of the developing semilunar valve tissues in embryos deficient in phosphollipase Cepsilon. These results suggest a crucial role of phosphollipase Cepsilon downstream of the epidermal growth factor receptor in controlling semillunar vaivulogenesis through inhibition of bone morphogenetic protein signaling.